Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01292772
Other study ID # UPCC 12110
Secondary ID
Status Completed
Phase
First received
Last updated
Start date December 2010
Est. completion date May 5, 2019

Study information

Verified date April 2020
Source Abramson Cancer Center of the University of Pennsylvania
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The primary objective of this study is to use LR imaging to evaluate the effects of adjuvant radiation therapy on reconstructed breasts.


Description:

Immediate breast reconstruction following mastectomy has become an increasingly popular and accepted treatment option among breast cancer patients. This change in practice has resulted in a significant number of patients who undergo radiation therapy after breast reconstruction. Following irradiation, the reconstructed breast often experiences fibrotic contracture, volume loss, altered pigmentation, or some combination thereof, producing an asymmetric and aesthetically compromised result. The effects of radiation on reconstructed breasts as well as the implications that such changes have for timing of reconstructive surgery, post-operative management and surveillance imaging are topics of growing importance in plastic surgery, radiology and surgical oncology.


Recruitment information / eligibility

Status Completed
Enrollment 12
Est. completion date May 5, 2019
Est. primary completion date December 2016
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria:

- Female patients between 18 and 90 years of age.

- Patients with a diagnosis of unilateral breast cancer who elect to undergo bilateral mastectomy with immediate free flap reconstruction.

- Patients must also have a locally advanced tumor that requires adjuvant radiation therapy following reconstruction.

Exclusion Criteria:

- Women who do not undergo immediate, bilateral breast reconstruction using a free flap.

- Women who do not require unilateral, adjuvant radiation therapy

- Women who are pregnant

- Women who have altered renal function, defined as a personal history of diabetic, hypertensive or autoimmune nephropathy and/or on routine preoperative testing are found to have a serum creatinine greater than or equal to 1.3

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
contract-enhanced MRI
Patients will have contrast-enhanced MRI of the breasts.
Radiation:
Unilateral Adjuvant Radiation Therapy
The study group will consist breasts receiving post-operative radiation, and the control group will consist of the patient's breasts on the non-radiated side. In this way, patients will act as their own control.

Locations

Country Name City State
United States Abramson Cancer Center of the University of Pennsylvania Philadelphia Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
Abramson Cancer Center of the University of Pennsylvania

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Reconstructed Breast Volume This will be compared at 2 points: before radiation and 1 year after radiation is completed between the 2 breasts. up to 1 year after radiation
Primary Vascular Fibrosis This will be compared at 2 points: before radiation and 1 year after radiation is completed between the 2 breasts. up to 1 year after radiation
Primary Dermal Thickness This will be compared at 2 pionts: before radiation and 1 year after radiation is completed between the 2 breasts up to 1 year after radiation
Secondary Presence of Fat Necrosis in the Breast This will be assessed at 2 points: before radiation and 1 year after radiation is completed between the 2 breasts. up to 1 year after radiation
Secondary Evidence of Cancer Recurrence This will assessed at 2 points: before radiation and 1 year after radiation is completed between the 2 breasts. up to 1 year after radiation
Secondary Symmetry This will be assessed at 2 points; before radiation and 1 year after radiation is completed between the 2 breasts. up to 1 year after radiation
Secondary Hyperpigmentation This will be assessed at 2 points: before radiation and 1 year after radiation is completed between the 2 breasts. up to 1 year after radiation
Secondary Contracture This will be assessed at 2 points:before radiation and 1 year after radiation is completed between the 2 breasts. up to 1 year after radiation
Secondary Aesthetic Result This will be assessed at 2 points: before radiation and 1 year after radiation is completed between the 2 breasts. up to 1 year after radiation
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A